Target- |
MechanismCell membrane permeability enhancers |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Ethigen, Inc.
0 Patents (Medical) associated with Ethigen, Inc.
100 Deals associated with Ethigen, Inc.
100 Translational Medicine associated with Ethigen, Inc.